{
    "2021-01-07": [
        [
            {
                "time": "",
                "original_text": "高瓴资本的两只医药龙头，无惧利空又双叒叕创新高",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "医药龙头",
                        "利空",
                        "创新高"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "盘点医药集采三年得失 医疗板块大落大起后何去何从",
                "features": {
                    "keywords": [
                        "医药集采",
                        "医疗板块",
                        "大落大起"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}